BANGKOK: Only 60% of rare disease patients in Malaysia are receiving treatment, says the head of the Genetics and Metabolism Unit at Universiti Malaya’s Paediatrics Department.
Dr Tae Sok Kun said in Malaysia, based on the findings of a recent study conducted by the School of Pharmaceutical Sciences at Universiti Sains Malaysia and Universiti Malaya Medical Centre, only 60% of rare disease patients were receiving treatment.
